Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Noninvasive brain and nerve stimulation to improve hand grasp after cervical spinal cord injury

Official title: Neuromodulation to Improve Grasping Function After Spinal Cord Injury

Run by State University of New York at Buffalo · NCT07433959 · Data updated 2026-11-12

This trial will test whether combining noninvasive brain stimulation (iTBS) and paired corticospinal-motoneuronal stimulation with hand exercises can improve grasping in people with chronic cervical spinal cord injury.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment54 (estimated)
SponsorState University of New York at Buffalo
Academic / other
Locations1 site (Buffalo, New York)
StatusRecruiting
StartedApril 1, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedApril 23, 2026
Trial IDNCT07433959 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–75 with chronic (≥1 year) cervical incomplete spinal cord injury at C8 or above who have measurable motor-evoked potentials in at least one first dorsal interosseous (FDI) muscle.

Probably not a fit

People with uncontrolled medical conditions, a history of seizures, metal skull implants, or those taking medications that lower the seizure threshold are unlikely to be eligible or to benefit from the stimulation protocols.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The protocol pairs intermittent theta burst stimulation (iTBS) applied to primary motor cortex with paired corticospinal-motoneuronal stimulation (PCMS) of peripheral nerves to strengthen late corticospinal descending signals. In Part 1, 30 participants complete two randomized sessions comparing the combined stimulation approach to control/sham to measure immediate neurophysiological effects. In Part 2, 24 participants are randomized to receive either the combined stimulation protocol or sham stimulation alongside a program of long-term hand grasp training to measure functional gains. Outcomes include motor-evoked potentials and measures of hand motor function.

Why it matters

Potential benefit: If successful, the approach could improve hand strength and grasp function, increasing independence in daily activities for people with cervical incomplete spinal cord injury.

How similar studies have gone: Previous small human and animal studies have shown that PCMS and iTBS can enhance corticospinal plasticity, but combining both techniques with long-term motor training in this population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For individuals with SCI:

* Ages 18-75 years
* Chronic SCI (≥1 year of injury)
* Cervical injury at C8 or above
* Individuals who have MEP responses in at least one FDI muscle

Exclusion Criteria:

* Uncontrolled medical problems including pulmonary or cardiovascular disease
* Premorbid, ongoing major depression or psychosis, altered cognitive status
* History of head injury or stroke
* Metal plate in skull
* History of seizures
* Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs
* Pregnant females
* Individuals who suffer from a spinal cord disease such as spinal stenosis, spinal bifida or herniated cervical

Where it's running

  • The State University of New York at Buffalo
    Buffalo, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.